Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy

OBJECTIVE: To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. MATERIALS AND METHODS: A total of 76 patients with calcium calculi who were stone-free or had residual stones less than 4 mm fol...

Full description

Bibliographic Details
Main Authors: B Lojanapiwat, M Tanthanuch, C Pripathanont, S Ratchanon, S Srinualnad, T Taweemonkongsap, S Kanyok, S Lammongkolkul
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2011-10-01
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000500007
_version_ 1828837426212110336
author B Lojanapiwat
M Tanthanuch
C Pripathanont
S Ratchanon
S Srinualnad
T Taweemonkongsap
S Kanyok
S Lammongkolkul
author_facet B Lojanapiwat
M Tanthanuch
C Pripathanont
S Ratchanon
S Srinualnad
T Taweemonkongsap
S Kanyok
S Lammongkolkul
author_sort B Lojanapiwat
collection DOAJ
description OBJECTIVE: To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. MATERIALS AND METHODS: A total of 76 patients with calcium calculi who were stone-free or had residual stones less than 4 mm following ESWL and PCNL were enrolled. All patients were independently randomized into two groups. The treated group (N = 39) was given 81 mEq per day of oral potassium-sodium citrate (27 mEq three times a day), and the untreated group (N = 37) serving as controls. Blood, twenty-four hour urine analysis, and plain KUB were measured and compared at the baseline and after 12 months. RESULTS: At baseline, hypocitraturia was found in 20 of 39 patients (46.05%) of Group I and 15 of 37 patients (40.5%) of Group II. At 12 months, hypocitraturia was found in 3 of 39 (7.69%) and 14 of 37 (37.83%) of Group I and Group II, respectively (p = 0.007). At the 12 month follow-up, of the stone-free group, 92.3% of the treated group and 57.7% of the control group were still stone free. Of the residual stone group, 30.8% and 9.1 % of treated and control group were stone-free, respectively. The increased stone size found in 7.7% and 54.5% of treated and control groups, respectively. CONCLUSION: Sodium-potassium citrate provides positive effects on stone-forming activities in calcium stone patients suffering from urolithiasis following treatment with ESWL and PCNL procedures at the 12-month follow-up.
first_indexed 2024-12-12T18:40:36Z
format Article
id doaj.art-bdc4e8ac68304d6c8340b370eeb45559
institution Directory Open Access Journal
issn 1677-5538
1677-6119
language English
last_indexed 2024-12-12T18:40:36Z
publishDate 2011-10-01
publisher Sociedade Brasileira de Urologia
record_format Article
series International Brazilian Journal of Urology
spelling doaj.art-bdc4e8ac68304d6c8340b370eeb455592022-12-22T00:15:39ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-55381677-61192011-10-0137561161610.1590/S1677-55382011000500007Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomyB LojanapiwatM TanthanuchC PripathanontS RatchanonS SrinualnadT TaweemonkongsapS KanyokS LammongkolkulOBJECTIVE: To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. MATERIALS AND METHODS: A total of 76 patients with calcium calculi who were stone-free or had residual stones less than 4 mm following ESWL and PCNL were enrolled. All patients were independently randomized into two groups. The treated group (N = 39) was given 81 mEq per day of oral potassium-sodium citrate (27 mEq three times a day), and the untreated group (N = 37) serving as controls. Blood, twenty-four hour urine analysis, and plain KUB were measured and compared at the baseline and after 12 months. RESULTS: At baseline, hypocitraturia was found in 20 of 39 patients (46.05%) of Group I and 15 of 37 patients (40.5%) of Group II. At 12 months, hypocitraturia was found in 3 of 39 (7.69%) and 14 of 37 (37.83%) of Group I and Group II, respectively (p = 0.007). At the 12 month follow-up, of the stone-free group, 92.3% of the treated group and 57.7% of the control group were still stone free. Of the residual stone group, 30.8% and 9.1 % of treated and control group were stone-free, respectively. The increased stone size found in 7.7% and 54.5% of treated and control groups, respectively. CONCLUSION: Sodium-potassium citrate provides positive effects on stone-forming activities in calcium stone patients suffering from urolithiasis following treatment with ESWL and PCNL procedures at the 12-month follow-up.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000500007kidneycalculilithotripsycitratesurolithiasis
spellingShingle B Lojanapiwat
M Tanthanuch
C Pripathanont
S Ratchanon
S Srinualnad
T Taweemonkongsap
S Kanyok
S Lammongkolkul
Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
International Brazilian Journal of Urology
kidney
calculi
lithotripsy
citrates
urolithiasis
title Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
title_full Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
title_fullStr Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
title_full_unstemmed Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
title_short Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
title_sort alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
topic kidney
calculi
lithotripsy
citrates
urolithiasis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000500007
work_keys_str_mv AT blojanapiwat alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT mtanthanuch alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT cpripathanont alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT sratchanon alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT ssrinualnad alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT ttaweemonkongsap alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT skanyok alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT slammongkolkul alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy